Takeda - M&A Summary and Business Overview

Life ScienceCompany

Takeda M&A Summary

Takeda has acquired 22 companies, including 6 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 6 assets.

Takeda’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2015, when it sold Takeda Pharmaceutical Company - Core Respiratory Business to AstraZeneca for $575M. Takeda has acquired in 6 different US states, and 5 countries. The Company’s most targeted sectors include life science (95%) and healthcare services (6%).

Takeda Business Overview

Where is Takeda headquartered?

Takeda is headquartered in Tokyo, Japan.

What is Takeda’s revenue?

Takeda disclosed revenue of 4,027,478M JPY for 2023 and 3,569,006M JPY for 2022.

How many employees does Takeda have?

Takeda has 47,347 employees.

What sector is Takeda in?

Takeda is a life science company.

When was Takeda founded?

Takeda was founded in 1781.

M&A Summary

  • M&A Total Activity24
    • M&A Buy Activity18
    • M&A Sell Activity6
  • Total Sectors Invested 2
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 15
  • M&A Advisors 8

Takeda

Takeda Pharmaceutical Co., Ltd.

1-1, Nihonbashi-Honcho 2-chome Chuo-ku,
Tokyo, 103-8668
Japan,
+81 3 3278 2111
www.takeda.com

Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was originally established in 1781 and is based in Tokyo, Japan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.2/yr) # 12 1 2 3 - - 18
vol $93.0B $525M $93.5B
Sell (0.6/yr) # 3 3 - - - - 6
vol $775M $842M $1.6B
  24

Most Recent M&A

Company Date Value Type
Nimbus Lakshmi, Inc. 2022-12-13 - Divestiture
Cambridge, Massachusetts
Nimbus Therapeutics - NDI-034858 2022-12-13 - Divestiture
Cambridge, Massachusetts
Adaptate Biotherapeutics Ltd. 2022-01-10 - Add-on Acquisition
London, United Kingdom · www.adaptate.com
GammaDelta Therapeutics Ltd. 2021-10-27 - Add-on Acquisition
London, United Kingdom · www.gammadeltatx.com
Maverick Therapeutics 2021-03-09 525M USD Add-on Acquisition
Brisbane, California · www.mavericktx.com
Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets 2020-11-30 278M USD Divestiture
Osaka, Japan
TachoSil 2020-09-16 564M USD Divestiture
Osaka, Japan
Takeda Pharmaceutical Co.,Ltd. - Buccolam 2020-09-14 - Divestiture
Osaka, Japan
PvP Biologics, Inc. 2020-02-26 - Add-on Acquisition
San Diego, California · www.pvpbio.com
Takeda Pharmaceutical Co.,Ltd. - Primary Care Portfolio 2019-10-15 200M USD Divestiture
Osaka, Japan
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Takeda Pharmaceuticals U.S.A., Inc.    - Gaido Health 2020-04-16 2
Deerfield, Illinois · www.takeda.us Los Angeles, California
Takeda Pharmaceuticals U.S.A., Inc.    - URL Pharma, Inc. 2012-12-17 1
Deerfield, Illinois · www.takeda.us Philadelphia, Pennsylvania · www.urlpharma.com
Millennium Pharmaceuticals, Inc.    - LeukoSite, Inc. 1999-12-22 1
Cambridge, Massachusetts · www.millennium.com Cambridge, Massachusetts

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 17 (94%) 93.5B (100%) 3 (50%) 853M (53%)
Medical Products - - 3 (50%) 764M (47%)
Healthcare Services 1 (6%) 35M (< 1%) - -
Total 18 $93.5B 6 $1.6B

By Geo

State/Country Buy Value Sell Value
United States 12 15.0B - -
  Massachusetts 4 14.0B - -
  California 4 715M - -
  Montana 1 60M - -
  Minnesota 1 - - -
  Florida 1 140M - -
  Colorado 1 35M - -
Japan - - 5 1.6B
United Kingdom 3 - - -
Switzerland 1 10.8B 1 -
Belgium 1 - - -
Ireland 1 67.7B - -
Domestic - - 5 (83%) 1.6B (100%)
Cross-border 18 (100%) 93.5B (100%) 1 (17%) -
Total 18 $93.5B 6 $1.6B

Top M&A Advisors

Financial Deals
Evercore Group
2
UBS Investment Bank
1
Nomura Investment Bank
1
Legal Deals
Cleary Gottlieb Steen & Hamilton
2
Edwards Wildman Palmer LLP
1
Polsinelli PC
1

Deal Values

buy # Total
> $1B 4 $92.6B
$100M to $1B 3 $855M
< $100M 2 $95M
TOTAL $93.5B
Largest Shire plc
$67.7B (2018-05-08)
sell # Total
$100M to $1B 4 $1.6B
TOTAL $1.6B
Largest Takeda Pharmaceutical Company - Core Respiratory Business
$575M (2015-12-16)

M&A Connections

Deals
Acquired from
Investor(s)
17%
3 (17%)
Strategic(s)
17%
3 (17%)
Divested to
Strategic(s)
100%
6 (100%)

 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Takeda

Life Science Companies , Japan Companies